15 YEARS OF PARAGANGLIOMA: Genetics and Mechanism of Pheochromocytoma–paraganglioma Syndromes Characterized by germlineSDHBandSDHDmutations

Endocrine-Related Cancer - United Kingdom
doi 10.1530/erc-15-0226
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Bioscientifica

Related search

FGF21 Levels in Pheochromocytoma/Functional Paraganglioma

Cancers
Cancer ResearchOncology
2019English

The Clinical Genetics of Phaeochromocytoma and Paraganglioma

Archives of endocrinology and metabolism
EndocrinologyMetabolismDiabetes
2017English

Metabolic Implications of Hypoxia and Pseudohypoxia in Pheochromocytoma and Paraganglioma

Cell and Tissue Research
Forensic MedicinePathologyHistologyCell Biology
2018English

Therapies Targeting the Signal Pathways of Pheochromocytoma and Paraganglioma

OncoTargets and Therapy
OncologyPharmacology
2019English

Pheochromocytoma and Paraganglioma: Understanding the Complexities of the Genetic Background

Cancer genetics
Cancer ResearchGeneticsMolecular Biology
2012English

Distinct Clinical Features of Paraganglioma Syndromes Associated With

JAMA - Journal of the American Medical Association
Medicine
2004English

Role of MDH2 Pathogenic Variant in Pheochromocytoma and Paraganglioma Patients

Genetics in Medicine
MedicineGenetics
2018English

Precision Medicine in Pheochromocytoma and Paraganglioma: Current and Future Concepts

Journal of Internal Medicine
Internal Medicine
2016English

Hepatic Metastatic Paraganglioma 12 Years After Retroperitoneal Paraganglioma Resection: A Case Report

BMC Gastroenterology
MedicineGastroenterology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy